Who invested in Thousand Oaks Biopharmaceuticals?
Thousand Oaks Biopharmaceuticals's investors include Hill House Capital, CDH Investments, CICC, Addor Capital and Highlight Capital.
Who invested in Thousand Oaks Biopharmaceuticals
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2022, from 1 source
- Latest round
- VentureJul 2022
- Investors
- 5
The rounds
- Jul 2022VentureAmount undisclosed
Source recorded
Everyone who backed them
CICCInvestment bank1round
Highlight CapitalVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Thousand Oaks Biopharmaceuticals
How much has Thousand Oaks Biopharmaceuticals raised?
Thousand Oaks Biopharmaceuticals has raised 1 round since 2022, none with a disclosed amount.
When did Thousand Oaks Biopharmaceuticals last raise?
Thousand Oaks Biopharmaceuticals's most recent round was a Venture in Jul 2022.
Who backed Thousand Oaks Biopharmaceuticals first?
Thousand Oaks Biopharmaceuticals's first round on record, in Jul 2022, was backed by Hill House Capital, CDH Investments and CICC and 2 others.
What stage is Thousand Oaks Biopharmaceuticals at?
Thousand Oaks Biopharmaceuticals's latest named round is a Venture, in Jul 2022.
Companies like Thousand Oaks Biopharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.